The Weekly Roundup

February 26, 2016 | Pamela Youngberg Dickson

In pharmacy, we seem to find ourselves talking about antitrust with some frequency. I speculate the industry presents some variables (reliable access to drugs, patient choice, the desire for cost containment, et. al.) that can make enforcing the law in the U.S. healthcare cartel (too strong a word?) a challenge. So, while we watchdog industry consolidation (a bit late), roll our eyes at Shkreli’s comeuppance, and scratch our heads each month trying to understand how DIR fees are even legal, here’s an interesting opinion piece specific to competition, patent expiration, and innovation in the insulin marketplace. Here are a couple other pieces we think you might like:

  • Some thoughts on EHR and its role in improving patient care today, and its value as a research tool to shape care in the future.
  • I have the Geek Squad on speed dial. But we’ve been hearing about a new virus responsible for a lot of headaches in IT departments over the past couple of weeks. Here’s some insight.
  • If you’re still focused on your New Year’s resolutions, here are some thoughts on leadership, the art of compromise, and the balance to be struck between short-term and long-term goals. (Not an ideal read for Panther fans.)

[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across this week. We hope you’ll share some of your favorites, too. Keep us in the loop and note “Weekly Roundup” in the comment box, or reply here.

AntitrustdiabetesLeadershipWeekly Roundup

Pamela Youngberg Dickson

Before she came to Smart-Fill, Pamela developed marketing strategy and content for a range of technology start-ups and large-cap enterprises. Outside the office, she's into gardening, renaissance history, the Big Ten, and exploring the great outdoors.